Reducing Chronic Kidney Disease Burden in an Underserved Population

Clinical Trial ID NCT03832166

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03832166

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010 16.00
2 Disease and disadvantage in the United States and in England. JAMA 2006 11.78
3 Racial differences in incident heart failure among young adults. N Engl J Med 2009 5.60
4 APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013 5.00
5 Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003 4.28
6 Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet 2014 3.97
7 Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int 2011 3.48
8 Facilitating internalization: the self-determination theory perspective. J Pers 1994 2.78
9 Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010. JAMA 2015 2.26
10 A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol 2013 2.13
11 Understanding why patients of low socioeconomic status prefer hospitals over ambulatory care. Health Aff (Millwood) 2013 1.82
12 Validity and calibration of food frequency questionnaires used with African-American adults in the Jackson Heart Study. J Am Diet Assoc 2009 1.67
13 Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy. Clin J Am Soc Nephrol 2014 1.65
14 Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study. Arch Intern Med 2006 1.54
15 Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int Suppl 2003 1.50
16 Medical costs of CKD in the Medicare population. J Am Soc Nephrol 2013 1.45
17 Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA 2015 1.38
18 A systematic review of behavioral interventions to promote intake of fruit and vegetables. J Am Diet Assoc 2011 1.29
19 Developing dietary assessment tools. J Am Diet Assoc 2004 1.28
20 An overview of "The Active by Choice Today" (ACT) trial for increasing physical activity. Contemp Clin Trials 2007 1.16
21 An overview of the "Positive Action for Today's Health" (PATH) trial for increasing walking in low income, ethnic minority communities. Contemp Clin Trials 2010 1.16
22 Are biomarkers useful treatment aids for promoting health behavior change? An empirical review. Am J Prev Med 2002 1.13
23 Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int 2014 1.06
24 Cost-effectiveness of screening for microalbuminuria among African Americans. J Am Soc Nephrol 2012 1.02
25 Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc 2014 1.01
26 State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol 2014 0.99
27 Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol 2015 0.98
28 Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol 2013 0.93
29 An overview of the Families Improving Together (FIT) for weight loss randomized controlled trial in African American families. Contemp Clin Trials 2015 0.88
30 Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA. Clin Kidney J 2015 0.86
31 Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis. Nephrol Dial Transplant 2015 0.81
32 Added value of screening for CKD among the elderly or persons with low socioeconomic status. Clin J Am Soc Nephrol 2015 0.80
33 Kidney disease progression and screening cost-effectiveness among African Americans. J Am Soc Nephrol 2012 0.80
34 Albuminuria: is it time to screen the general population? Adv Chronic Kidney Dis 2011 0.79
35 Evaluating risk of ESRD in the urban poor. J Am Soc Nephrol 2014 0.78
36 Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int 2016 0.75
37 Community-based participatory research to design a faith-enhanced diabetes prevention program: The Better Me Within randomized trial. Contemp Clin Trials 2017 0.75
38 Distal, intermediate, and proximal mediators of racial disparities in renal disease mortality in the United States. J Nephropathol 2015 0.75
39 Federal Funding for Kidney Disease Research: A Missed Opportunity. Am J Public Health 2016 0.75
40 Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors. J Am Coll Cardiol 2017 0.75
41 To screen or not to screen: that is not (yet) the question. Clin J Am Soc Nephrol 2015 0.75
42 Understanding a Value Chain in Health Care. J Spinal Disord Tech 2015 0.75
43 Screening for elevated albuminuria and subsequently hypertension identifies subjects in which treatment may be warranted to prevent renal function decline. Nephrol Dial Transplant 2016 0.75
Next 100